Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in precision medicine
4.1.2 Research and development for clinical trials
4.1.3 Advancement in Biobanks Marketing techniques
4.2 Restraints
4.2.1 Surveillance issues
4.2.2 Problems in storage
4.2.3 Expensive procedures
4.3 Opportunities
4.3.1. Research and understanding on various diseases
4.4 Challenges
4.4.1. Informatics
Chapter 5 North America Biobank Drug Discovery & Regenerative Medicine Market - By Application
5.1 Regenerative medicine
5.2 Life Science Research
5.3 Disease Research
5.4 Drug Discover
Chapter 6 North America Biobank Drug Discovery & Regenerative Medicine Market - By Country
6.1 Introduction
6.2 North America
6.2.1. The U.S.
6.2.2. Canada
6.2.3. Mexico
Chapter 7 North America Biobank Drug Discovery & Regenerative Medicine Market - Company Profiles
7.1 Tissue Solutions
7.2 Core Dynamics Ltd.
7.3 Taylor-Wharton
7.4 Qiagen N.V.
7.5 BioCision
7.6 Cryo BioSystems
7.7 Tecan
7.8 DNA Genotek Inc.
7.9 Bio Storage Technologies
7.10 Stemcell Technologies Inc.
7.11 Hamilton Company
7.12 Thermo Fisher Scientific Inc.
7.13 Chart Industries, Inc.
7.14 Beckman Coulter
Chapter 8 North America Biobank Drug Discovery & Regenerative Medicine Market - Competitive Landscape
8.1. Market Share Analysis
8.2. Strategies Adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
